Selective 5-HT6 receptor ligands: Progress in the development of a novel pharmacological approach to the treatment of obesity and related metabolic disorders
David J. Heal(Nexor (United Kingdom)), Helmut Buschmann, Angels Fisas, Sharon L. Smith(Unknown), Xavier Codony
Cited by 183
Related Papers
Amphetamine, past and present – a pharmacological and clinical perspective
|Journal of Psychopharmacology|2013|614
Experimental Approaches to Anxiety and Depression
|Behavioural Pharmacology|1993|363
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
|Journal of Psychopharmacology|2014|284
The pharmacology of the behavioral and hypothermic responses of rats to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)
|Psychopharmacology|1987|198
The neuropharmacology of ADHD drugs in vivo: Insights on efficacy and safety
|Neuropharmacology|2009|197